Monday, March 3rd, 2008
Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced that the U.S. Food and Drug Administration has granted final approval for the Company's Abbreviated New Drug Application (ANDA) to market its generic version of Pfizer's chemotherapy agent, Camptosar(R) (Irinotecan Hydrochloride) Injection, 20 mg/mL. Shipment of this product, available in 40 mg/2 mL ...
Posted in Pharma Industry | No Comments »
Thursday, February 28th, 2008
PrimeGen Biotech announced that company researchers have successfully used purified proteins and DNAs in non-viral methods to reprogram adult human cells into stem cells.
Participating in this week's Stem Cell Summit in New York, the company reported that this new class of stem cells -- derived from adult human tissues such ...
Posted in Stem Cell Research | No Comments »
Thursday, February 28th, 2008
GE Healthcare IT announced that many of its Centricity(R) solutions, including Centricity Health Information Exchange (HIE) Services, passed important integration profiles established by Integrating the Healthcare Enterprise (IHE). The IHE testing process is a critical step in achieving systems interoperability to enhance the quality of patient care. Many of these ...
Posted in IT / Internet / E-mail | No Comments »
Tuesday, February 26th, 2008
The U.S. Food and Drug Administration announced that Brownwood Acres Foods Inc., Cherry Capital Services Inc. (doing business as Flavonoid Sciences) and two of their top executives have signed a consent decree that effectively prohibits the companies and their executives from manufacturing and distributing any products with claims in the ...
Posted in Nutrition / Diet | No Comments »
Monday, February 25th, 2008
Corgenix Medical Corporation (OTCBB: CONX), a worldwide developer and marketer of diagnostic test kits, has received notification of European Patent Office (EPO) approval for technology to which Corgenix holds exclusive worldwide licensing rights.
McMaster University (McMaster) of Hamilton, Ontario, is the owner of the patent covering the aspirin resistance measurement method. ...
Posted in Medical Devices | No Comments »
Monday, February 25th, 2008
Health Secretary Alan Johnson announced a package of measures to recruit an extra 4,000 midwives to the NHS over the next three years.
During a visit to Royal Victoria Infirmary Maternity Unit in Newcastle, the Health Secretary will outline plans to give former midwives a 'golden hello' worth up to £3,000 ...
Posted in Nursing | No Comments »
Saturday, February 23rd, 2008
ISTA Pharmaceuticals, Inc. (Nasdaq: ISTA), announced the acceptance of an abstract describing the results of a study using Xibrom(TM) (bromfenac ophthalmic solution) 0.09% therapy in combination with Lucentis(R) (ranibizumab injection) in patients with age-related macular degeneration (AMD). According to the abstract, patients who received Xibrom required 1.6 +/- 0.69 injections ...
Posted in Eye Health / Optometry | No Comments »
Friday, February 22nd, 2008
GE Healthcare announced that Memorial Hospital North is the first healthcare institution to deploy ApexPro® FH, a spread-spectrum frequency hopping telemetry system, on its CARESCAPE™ Enterprise Access™ in-building wireless platform. The solution provides the hospital with a single, integrated, wireless platform that enables critical patient data to be securely coordinated, ...
Posted in IT / Internet / E-mail | No Comments »
Friday, February 22nd, 2008
Stem Cell Therapeutics Corp. ("SCT") (TSX VENTURE:SSS) is pleased to announce favorable results from the investigator led BETAS (Beta-hCG + Erythropoietin in Acute Stroke), Phase IIa, open label, safety trial conducted at the University of California, Irvine and Hoag Presbyterian Memorial Hospital, Newport Beach, CA. This trial is the first ...
Posted in Stroke / Neuroprotection | No Comments »
